Acadian Asset Management Portfolio holdings
AUM
$48.4B
This Quarter Return
-3.78%
1 Year Return
+32.04%
3 Year Return
+133.69%
5 Year Return
+272.69%
10 Year Return
+761.99%
AUM
$18.3B
AUM Growth
+$18.3B
(-6.5%)
Cap. Flow
+$237M
Cap. Flow
% of AUM
1.3%
Top 10 Holdings %
Top 10 Hldgs %
17.81%
Holding
1,942
New
257
Increased
580
Reduced
588
Closed
267
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$178M |
| 2 |
Qiagen
QGEN
|
$124M |
| 3 |
Check Point Software Technologies
CHKP
|
$88.5M |
| 4 |
Murphy USA
MUSA
|
$78M |
| 5 |
Coca-Cola Europacific Partners
CCEP
|
$64.9M |
Top Sells
| 1 |
GSK
GSK
|
$124M |
| 2 |
Canadian Natural Resources
CNQ
|
$74.6M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$67.8M |
| 4 |
Deutsche Bank
DB
|
$60.4M |
| 5 |
Motorola Solutions
MSI
|
$55.4M |
Sector Composition
| 1 | Technology | 24.14% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Staples | 13.67% |
| 4 | Materials | 8.84% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$3.45T
| $584M | 3.2% | 4,226,374 +53,954 | +1% | +$7.46M |
|
2
Microsoft
MSFT
$3.77T
| $446M | 2.44% | 1,914,354 -54,982 | -3% | -$12.8M |
|
|
3
Check Point Software Technologies
CHKP
$20.7B
| $336M | 1.84% | 2,995,634 +789,980 | +36% | +$88.5M |
|
4
McKesson
MCK
$85.4B
| $331M | 1.81% | 973,493 -31,828 | -3% | -$10.8M |
|
5
PepsiCo
PEP
$204B
| $331M | 1.81% | 2,025,733 +106,181 | +6% | +$17.3M |
|
6
Hershey
HSY
$37.3B
| $299M | 1.63% | 1,355,731 +59,353 | +5% | +$13.1M |
|
7
Berkshire Hathaway Class B
BRK.B
$1.09T
| $256M | 1.4% | 958,406 +23,526 | +3% | +$6.28M |
|
8
Reliance Steel & Aluminium
RS
$15.5B
| $233M | 1.27% | 1,334,891 -232,792 | -15% | -$40.6M |
|
9
Atlassian
TEAM
$46.6B
| $228M | 1.25% | 1,084,651 -37,749 | -3% | -$7.95M |
|
10
Molina Healthcare
MOH
$9.8B
| $213M | 1.17% | 647,203 +6,378 | +1% | +$2.1M |
|
|
11
Alphabet (Google) Class A
GOOGL
$2.57T
| $193M | 1.06% | 2,017,566 +1,860,609 | +1,185% | +$178M |
|
|
12
GSK
GSK
$79.9B
| $192M | 1.05% | 6,511,762 -4,218,492 | -39% | -$124M |
|
|
13
Regeneron Pharmaceuticals
REGN
$61.5B
| $180M | 0.98% | 260,995 -98,420 | -27% | -$67.8M |
|
14
Cisco
CSCO
$274B
| $178M | 0.97% | 4,448,579 +357,867 | +9% | +$14.3M |
|
15
Procter & Gamble
PG
$368B
| $172M | 0.94% | 1,365,081 -51,738 | -4% | -$6.53M |
|
16
Cadence Design Systems
CDNS
$95.5B
| $170M | 0.93% | 1,042,861 -9,162 | -0.9% | -$1.5M |
|
17
Bio-Rad Laboratories Class A
BIO
$8.06B
| $164M | 0.9% | 392,702 -10,304 | -3% | -$4.3M |
|
18
Johnson & Johnson
JNJ
$427B
| $156M | 0.85% | 956,447 +32,645 | +4% | +$5.33M |
|
19
Marsh & McLennan
MMC
$101B
| $151M | 0.83% | 1,014,822 +96,785 | +11% | +$14.4M |
|
20
Synopsys
SNPS
$112B
| $148M | 0.81% | 484,553 -4,877 | -1% | -$1.49M |
|
21
Elevance Health
ELV
$71.8B
| $148M | 0.81% | 324,831 +10,550 | +3% | +$4.79M |
|
22
Oracle
ORCL
$635B
| $140M | 0.77% | 2,300,426 +60,816 | +3% | +$3.71M |
|
|
JNPR
23
DELISTED
Juniper Networks
JNPR
| $140M | 0.76% | 5,342,666 -597,258 | -10% | -$15.6M |
|
24
Gilead Sciences
GILD
$140B
| $139M | 0.76% | 2,253,766 +152,669 | +7% | +$9.42M |
|
25
Colgate-Palmolive
CL
$67.9B
| $138M | 0.75% | 1,960,204 -28,911 | -1% | -$2.03M |
|